Modulação da microbiota intestinal com probióticos e sua relação com a obesidade

Autores

  • Deidiana Kelly Nascimento Souza Soares

Palavras-chave:

Probióticos, Microbioma gastrointestinal, Obesidade

Resumo

Objetivo: Avaliar os resultados a partir da modução intestinal com probióticos no tratamento da obesidade. Método: Foram realizados levantamentos bibliográficos nas bases de dados PUBMED, SCIELO e LILACS, publicados de 2006 a 2018, com as palavras- chave: probióticos, microbioma gastrointestinal e obesidade. Resultados: Nos estudos avaliados as cepas com maior utilização em animais e humanos foram as dos gêneros Lactobacillus e Bifidobacterium. Dentre os achados, a redução do peso e massa corporal, a diminuição da circunferência da cintura, gordura corporal e visceral foram os resultados mais encontrados. Conclusão: Apesar dos resultados, os trabalhos ainda apresentam poucas informações sobre a quantidade de cepas administradas e tempo de tratamento para o uso em prática clínica além da limitação das pesquisas em humanos sendo necessários mais estudos para o direcionamento da utilização de probióticos no tratamento da obesidade.

Referências

Silva Junior VL, Lopes FAM, Albano RM, Souza MGC, Barbosa CML, Maranhão PA, et al. Obesity and gut microbiota: what do we know so far? Medical Express, 2017; 4:1-11.

Carvalho Filho MA, Pauli JR, Ropelle ER, Cintra DEC. Obesidade e diabetes: da origem ao caos. Obesidade e Diabetes: Fisiopatologia e Sinalização Celular.Sarvier Editora de Livros Médicos, 2011; 1 (8): 2-10.

Beutler B, Hoebe K, Du X, Ulevitch RJ. How we detect microbies and respond to them: the Toll- like receptors and their transducers. Journal Leukoc Biol, 2003; 74 (4): 479-485.

Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, et al. Dietary intervention impact on gut microbial gene richness. Nature, UK, 2013; 500 (7464): 585-588.

Delzenne NM, Neyrinck AM, Cani PD. Gut microbiota and metabolic disorders: How prebiotic can word? British Journal of Nutrion, UK, 2013; 109 (Suppl 2): 81-85.

Hernell O, West CE. Clinical effects of probiotics: scientific evidence from a paediatric perspective. British Journal of Nutrion, UK, 2013; 109 (Suppl 2): 70-75.

Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. Na obesity-associated gut microbiome with increased capacity for energy harvest. Nature. USA, 2006; 444: 21-28.

Oliveira JMS, Santos GM, Saldanha NMVP, Sousa PVL, Carvalho ACS. Efeitos de probióticos no tratamento da obesidade. Revista Eletrônica da FAINOR: Vitória da Conquista, 2017; 10 (2): 154-165.

Valero Y, Colina J, Herrera H. La microbiota intestinal y su rol en la diabetes. Anales Venezolanos de Nutrición: Venezuela, 2015; 28 (2): 132-144.

MACHOWIAK, P.A. Recycling Metchnikoff probiotics: the intestinal microbiome and the quest for long life. Frontiers in public health, v.1, n. 52, 2013.

Paixão LA, Castro FFS. A colonização da microbiota intestinal e sua influência na saúde do hospedeiro. Ciências da Saúde, Brasília, 2016; (1): 85-96.

Sturmer ES, Casasola S, Gall MC, Gall MC. A importância dos probióticos na microbiota intestinal humana. Revista Brasileira de Nutrição Clínica: Rio grande do Sul, 2012; 27 (4): 4-72.

Khan MJ, Gerasimidis K, Edwards CA, Shaikh MG. Role of gut microbiota in the aetiology of obesity: proposed mechanisms and review of the literature. Journal of Obesity, 2016; 8: 1-27.

Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolim. Nature 2012; 489: 242-249.

Wu GD. Lining Long- Term Dietary Patterns with gut microbial enteropypes.Science, 2011; 334 (6052):105-108.

Faith JJ. Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL. The long-term stability of the human gut microbiota. Science, 2013; 341: 6141.

Food and Agriculture Organization and Word Helth Organization. Obesity and overweight. Facts sheet nº 311. 2014. Disponível em <http://www.who.int/mediacentre/factsheets/fs311/en/>. Acesso em 18 fev. 2018.

ABESO. Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica. Diretrizes brasileiras de obesidade. São Paulo, 4º ed, 2016.

Clarke SF, Murphy EF, Nilaweera K, Ross PR, Shanahan F, O’toole PW, et al. The gut microbiota and its relationship to diet and obesity: New insights. Gut Microbes, 2012; 3 (3): 186–202.

Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Cavaleiro RD, Gordon JI. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the United States of America, USA, 2005; 102 (31):11070–11075.

Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature London, 2006; 444 (7114): 1022-1023.

Blaut M, Klaus S. Intestinal microbiota and obesity. Handbook of Experimental Pharmacology, 2012; 209: 251-273.

Food and Agriculture Organization and Word Helth Organization . Guidelines for the Evaluation of Probiotics in Food. 2002. Disponível em <http://www.lume.ufrgs.br/bitstream/handle/10183/108988/000948985.pdf?sequence=1>. Acesso em 18 fev. 2018.

Food and Agriculture Organization and Word Helth Organization .. Health and Nutricional Properties of Probiotics in Food including Powder Milk whit Live Lactic Acid Bacteria. 2001. Disponível em <http://www.fao.org/3/a-a0512e.pdf>. Acesso em 18 fev.2018.

Worldgastroenterology. Guias Mundiais da WGO. 2011. Disponível em <http://www.worldgastroenterology.org/UserFiles/file/guidelines/probioticsportuguese-2011.pdf>. Acesso em 19 fev. 2018.

Arora T, Anastasovska J, Gibson G, Tuohy K, Sharma R, Bell J. Effect of Lactobacillus acidophilus NCDC 13 supplementation on the progression of obesity in diet- induced obese mice. British Journal of Nutrition, 2012; 108: 1382–1389.

Kadooka Y, Sato M, Ogawa A, Miyoshi, Uenishi H, Ogawa H. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. British Journal of Nutrition, 2013; 110: 1696–1703.

Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asgharijafarabadi M, Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition, 2012; 28 (5): 539-543.

Jung S P, Lee KM, Kang JH, Yun SI, Park HO, Moon. Effect of Lactobacillus gasseri BNR17 on Overweight and Obese Adults: A Randomized, Double-Blind Clinical Trial. The Korean Journal Family Medicine, 2013; 34: 80-89.

Sharafedtinov KK, Plotnikova OA, Alexeeva RI, Sentsova TB, Songiseppe Stsepetovaj, et al. Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients - a randomized double-blind placebo-controlled pilot study. Nutrition Journal, 2013;12: 138.

Park DY, Ahn YT, Park SH, Huh CS Yoo SR, Yu R, et al. Supplementation of Lactobacillus Curvatus HY7601 and Lactobacillus Plantarum KY1032 in Diet- Induced Obese Mice Is Associated with Gut Microbial Changes and Reduction in Obesity. PLOS ONE, 2013; 8 (3).

Cano PG, Santacruz A, Trejo FM, Sanz Y. Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in hight- fat- diet- fed mice. Obesity, USA, 2013; 21 (11): 2310- 2321.

Everard A, Matamoros S, Geurts L, Delminina NM, Cani PD. Saccharomyces Boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db/db Mice. MBio, USA, 2014; 5 (3).

Bomhof MR, Saha DC, Reid RT, Reid DT, Paul HA, Reimer RA. Combined effects of oligofructose and Bifidobacterium animalis on gut microbiota and glycemia in obese rats. Obesity, USA, 2014; 22 (3):763-771.

Nuñes IN, Galdeano CM, Leblanc Ade M, Perdigón G. Evaluation of imune response, microbiota, and blood markers after probiotic bactéria administration in obese mice induced by a high- fat diet. Nutrition, 2014; 30 (10-11): pg. 1423- 1432.

Hu X, Wang TAO, Wei LI, Feng JIN, Wang LI. Effects of NS Lactobacillus strains on lipid metabolism of rats fed a high cholesterol diet. Lipids in Health and Disease, USA, 2013; 9.

Lim SM, Jeong JJ, Woo KH, Han MJ, Kim DM. Lactobacillus sakei OK67 ameliorates high-fat diet–induced blood glucose intolerance and obesity in mice by inhibiting gut microbiota lipopolysaccharide production and inducing colon tight junction protein expression. Nutrition Research, 2016; 36 (4): 337- 48.

Sanchez M, Darimont C, Drapeau V, Emady-Azar S, Lepage M. Rezzonico. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. British Journal of Nutrition, 2014;111: 1507– 1519.

Gomes AC. Efeito da terapia complementar com probióticos sobre a composição corporal e a atividade das enzimas antioxidantes de mulheres com excesso de peso. Sistema de Bibliotecas UFG. Dissertação (Mestrado em Nutrição e Saúde) - Universidade Federal de Goiás; 2014.

Lee SJ, Bose S, Seo JG, Chung YS, Lim CY, Kim H. The effects of coadministration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: A randomized double-blind controlled clinical trial. Clinical Nutrition, 2014: 1-9.

Brahe LK, Chatelier LE, Prifti E, Pons N, Kennedy S, Faixa T, et al. Dietary Modulation of the Gut Microbiota- a Randomised Controlled Trial in Obese Postmenopausal Women. British Journal of Nutrition, UK, 2015; 114 (3): 406-417.

Publicado

2019-09-03

Como Citar

Soares, D. K. N. S. (2019). Modulação da microbiota intestinal com probióticos e sua relação com a obesidade. REVISA, 8(3), 356–366. Recuperado de https://rdcsa.emnuvens.com.br/revista/article/view/653

Edição

Seção

Revisão de Literatura